Dudediligence.

Elicio Therapeutics, Inc

ELTXNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Director nominationsSep 14 →InsidersNo open-market buys or sales.→HoldersKnoll 5.5%BlackRock 3.5%Vanguard 2.6%→Financing →PeersClosest companies: SNTI, JSPR, TRAW→

From the filings

Figures

Net income
−$37.8Mlast 12 months
Operating cash flow
−$38.5Mlast 12 months
Cash and equivalents
$23.5Mat the last balance sheet
Total debt
$9.5Mat the last balance sheet
Shares outstanding
21.9M shareson issue
Every year and quarter →